1	Johnson	_	NNP	_	_	4	SBJ	_	_
2	&	_	CC	_	_	1	COORD	_	_
3	Johnson	_	NNP	_	_	2	CONJ	_	_
4	reported	_	VBD	_	_	0	ROOT	_	_
5	a	_	DT	_	_	8	NMOD	_	_
6	10	_	CD	_	_	7	AMOD	_	_
7	%	_	NN	_	_	8	NMOD	_	_
8	rise	_	NN	_	_	4	OBJ	_	_
9	in	_	IN	_	_	8	LOC	_	_
10	third-quarter	_	JJ	_	_	12	NMOD	_	_
11	net	_	JJ	_	_	12	NMOD	_	_
12	income	_	NN	_	_	9	PMOD	_	_
13	on	_	IN	_	_	8	NMOD	_	_
14	a	_	DT	_	_	18	NMOD	_	_
15	12	_	CD	_	_	18	NMOD	_	_
16	%	_	NN	_	_	18	NMOD	_	_
17	sales	_	NNS	_	_	18	NMOD	_	_
18	increase	_	NN	_	_	13	PMOD	_	_
19	-	_	:	_	_	8	P	_	_
20	results	_	NNS	_	_	8	APPO	_	_
21	that	_	WDT	_	_	22	SBJ	_	_
22	were	_	VBD	_	_	20	NMOD	_	_
23	driven	_	VBN	_	_	22	VC	_	_
24	particularly	_	RB	_	_	25	PMOD	_	_
25	by	_	IN	_	_	23	LGS	_	_
26	new	_	JJ	_	_	27	NMOD	_	_
27	products	_	NNS	_	_	25	PMOD	_	_
28	including	_	VBG	_	_	27	NMOD	_	_
29	pharmaceuticals	_	NNS	_	_	28	PMOD	_	_
30	and	_	CC	_	_	29	COORD	_	_
31	the	_	DT	_	_	32	NMOD	_	_
32	company	_	NN	_	_	35	NMOD	_	_
33	's	_	POS	_	_	32	SUFFIX	_	_
34	professional	_	JJ	_	_	35	NMOD	_	_
35	operations	_	NNS	_	_	30	CONJ	_	_
36	.	_	.	_	_	4	P	_	_

1	Net	_	NN	_	_	13	SBJ	_	_
2	for	_	IN	_	_	1	NMOD	_	_
3	the	_	DT	_	_	9	NMOD	_	_
4	New	_	NNP	_	_	5	NAME	_	_
5	Brunswick	_	NNP	_	_	9	NMOD	_	_
6	,	_	,	_	_	5	P	_	_
7	N.J.	_	NNP	_	_	5	APPO	_	_
8	,	_	,	_	_	5	P	_	_
9	maker	_	NN	_	_	2	PMOD	_	_
10	of	_	IN	_	_	9	NMOD	_	_
11	health-care	_	NN	_	_	12	NMOD	_	_
12	products	_	NNS	_	_	10	PMOD	_	_
13	climbed	_	VBD	_	_	0	ROOT	_	_
14	to	_	TO	_	_	13	DIR	_	_
15	$	_	$	_	_	14	PMOD	_	_
16	265	_	CD	_	_	15	DEP	_	_
17	million	_	CD	_	_	15	DEP	_	_
18	,	_	,	_	_	15	P	_	_
19	or	_	CC	_	_	15	COORD	_	_
20	80	_	CD	_	_	21	NMOD	_	_
21	cents	_	NNS	_	_	19	CONJ	_	_
22	a	_	DT	_	_	23	NMOD	_	_
23	share	_	NN	_	_	21	ADV	_	_
24	,	_	,	_	_	13	P	_	_
25	from	_	IN	_	_	13	DIR	_	_
26	$	_	$	_	_	25	PMOD	_	_
27	240	_	CD	_	_	26	DEP	_	_
28	million	_	CD	_	_	26	DEP	_	_
29	,	_	,	_	_	26	P	_	_
30	or	_	CC	_	_	26	COORD	_	_
31	71	_	CD	_	_	32	NMOD	_	_
32	cents	_	NNS	_	_	30	CONJ	_	_
33	a	_	DT	_	_	34	NMOD	_	_
34	share	_	NN	_	_	32	ADV	_	_
35	,	_	,	_	_	26	P	_	_
36	in	_	IN	_	_	26	TMP	_	_
37	the	_	DT	_	_	39	NMOD	_	_
38	year-earlier	_	JJ	_	_	39	NMOD	_	_
39	period	_	NN	_	_	36	PMOD	_	_
40	.	_	.	_	_	13	P	_	_

1	Sales	_	NNS	_	_	2	SBJ	_	_
2	rose	_	VBD	_	_	0	ROOT	_	_
3	to	_	TO	_	_	2	DIR	_	_
4	$	_	$	_	_	3	PMOD	_	_
5	2.45	_	CD	_	_	4	DEP	_	_
6	billion	_	CD	_	_	4	DEP	_	_
7	from	_	IN	_	_	2	DIR	_	_
8	$	_	$	_	_	7	PMOD	_	_
9	2.2	_	CD	_	_	8	DEP	_	_
10	billion	_	CD	_	_	8	DEP	_	_
11	.	_	.	_	_	2	P	_	_

1	The	_	DT	_	_	4	NMOD	_	_
2	year-ago	_	JJ	_	_	4	NMOD	_	_
3	per-share	_	JJ	_	_	4	NMOD	_	_
4	earnings	_	NNS	_	_	5	SBJ	_	_
5	are	_	VBP	_	_	0	ROOT	_	_
6	adjusted	_	VBN	_	_	5	VC	_	_
7	to	_	TO	_	_	6	OPRD	_	_
8	reflect	_	VB	_	_	7	IM	_	_
9	a	_	DT	_	_	11	NMOD	_	_
10	2-for-1	_	JJ	_	_	11	NMOD	_	_
11	stock	_	NN	_	_	8	OBJ	_	_
12	split	_	VBD	_	_	11	NMOD	_	_
13	last	_	JJ	_	_	14	NMOD	_	_
14	May	_	NNP	_	_	11	TMP	_	_
15	.	_	.	_	_	5	P	_	_

1	In	_	IN	_	_	15	LOC	_	_
2	a	_	DT	_	_	3	NMOD	_	_
3	statement	_	NN	_	_	1	PMOD	_	_
4	,	_	,	_	_	15	P	_	_
5	Ralph	_	NNP	_	_	7	NAME	_	_
6	S.	_	NNP	_	_	7	NAME	_	_
7	Larsen	_	NNP	_	_	15	SBJ	_	_
8	,	_	,	_	_	7	P	_	_
9	chairman	_	NN	_	_	7	APPO	_	_
10	and	_	CC	_	_	9	COORD	_	_
11	chief	_	JJ	_	_	13	NMOD	_	_
12	executive	_	JJ	_	_	13	NMOD	_	_
13	officer	_	NN	_	_	10	CONJ	_	_
14	,	_	,	_	_	7	P	_	_
15	said	_	VBD	_	_	0	ROOT	_	_
16	the	_	DT	_	_	17	NMOD	_	_
17	company	_	NN	_	_	18	SBJ	_	_
18	was	_	VBD	_	_	15	OBJ	_	_
19	pleased	_	JJ	_	_	18	PRD	_	_
20	with	_	IN	_	_	19	AMOD	_	_
21	its	_	PRP$	_	_	24	NMOD	_	_
22	third-quarter	_	JJ	_	_	24	NMOD	_	_
23	sales	_	NNS	_	_	24	NMOD	_	_
24	performance	_	NN	_	_	20	PMOD	_	_
25	,	_	,	_	_	18	P	_	_
26	``	_	``	_	_	18	P	_	_
27	especially	_	RB	_	_	28	PMOD	_	_
28	in	_	IN	_	_	18	ADV	_	_
29	light	_	NN	_	_	28	PMOD	_	_
30	of	_	IN	_	_	29	NMOD	_	_
31	the	_	DT	_	_	34	NMOD	_	_
32	extremely	_	RB	_	_	34	NMOD	_	_
33	competitive	_	JJ	_	_	34	NMOD	_	_
34	environment	_	NN	_	_	30	PMOD	_	_
35	in	_	IN	_	_	34	LOC	_	_
36	domestic	_	JJ	_	_	38	NMOD	_	_
37	consumer	_	NN	_	_	38	NMOD	_	_
38	markets	_	NNS	_	_	35	PMOD	_	_
39	and	_	CC	_	_	34	COORD	_	_
40	the	_	DT	_	_	42	NMOD	_	_
41	negative	_	JJ	_	_	42	NMOD	_	_
42	impact	_	NN	_	_	39	CONJ	_	_
43	of	_	IN	_	_	42	NMOD	_	_
44	unfavorable	_	JJ	_	_	46	NMOD	_	_
45	exchange	_	NN	_	_	46	NMOD	_	_
46	rates	_	NNS	_	_	43	PMOD	_	_
47	this	_	DT	_	_	48	NMOD	_	_
48	quarter	_	NN	_	_	46	TMP	_	_
49	.	_	.	_	_	15	P	_	_
50	''	_	''	_	_	15	P	_	_

1	David	_	NNP	_	_	3	NAME	_	_
2	J.	_	NNP	_	_	3	NAME	_	_
3	Lothson	_	NNP	_	_	13	SBJ	_	_
4	,	_	,	_	_	3	P	_	_
5	an	_	DT	_	_	7	NMOD	_	_
6	industry	_	NN	_	_	7	NMOD	_	_
7	analyst	_	NN	_	_	3	APPO	_	_
8	for	_	IN	_	_	7	NMOD	_	_
9	PaineWebber	_	NNP	_	_	10	NAME	_	_
10	Group	_	NNP	_	_	8	PMOD	_	_
11	Inc.	_	NNP	_	_	10	POSTHON	_	_
12	,	_	,	_	_	3	P	_	_
13	said	_	VBD	_	_	0	ROOT	_	_
14	Johnson	_	NNP	_	_	18	NMOD	_	_
15	&	_	CC	_	_	14	COORD	_	_
16	Johnson	_	NNP	_	_	15	CONJ	_	_
17	's	_	POS	_	_	16	SUFFIX	_	_
18	results	_	NNS	_	_	20	SBJ	_	_
19	slightly	_	RB	_	_	20	EXT	_	_
20	exceeded	_	VBD	_	_	13	OBJ	_	_
21	his	_	PRP$	_	_	22	NMOD	_	_
22	expectations	_	NNS	_	_	20	OBJ	_	_
23	for	_	IN	_	_	22	NMOD	_	_
24	the	_	DT	_	_	26	NMOD	_	_
25	third	_	JJ	_	_	26	NMOD	_	_
26	quarter	_	NN	_	_	23	PMOD	_	_
27	.	_	.	_	_	13	P	_	_

1	In	_	IN	_	_	14	LOC	_	_
2	New	_	NNP	_	_	6	NMOD	_	_
3	York	_	NNP	_	_	6	NMOD	_	_
4	Stock	_	NNP	_	_	6	NMOD	_	_
5	Exchange	_	NNP	_	_	6	NMOD	_	_
6	composite	_	NN	_	_	1	PMOD	_	_
7	trading	_	VBG	_	_	6	NMOD	_	_
8	yesterday	_	NN	_	_	14	TMP	_	_
9	,	_	,	_	_	14	P	_	_
10	Johnson	_	NNP	_	_	14	SBJ	_	_
11	&	_	CC	_	_	10	COORD	_	_
12	Johnson	_	NNP	_	_	13	NMOD	_	_
13	shares	_	NNS	_	_	11	CONJ	_	_
14	fell	_	VBD	_	_	0	ROOT	_	_
15	37.5	_	CD	_	_	16	NMOD	_	_
16	cents	_	NNS	_	_	14	EXT	_	_
17	to	_	TO	_	_	14	DIR	_	_
18	$	_	$	_	_	17	PMOD	_	_
19	54.625	_	CD	_	_	18	NMOD	_	_
20	.	_	.	_	_	14	P	_	_

1	Mr.	_	NNP	_	_	2	TITLE	_	_
2	Larsen	_	NNP	_	_	3	SBJ	_	_
3	noted	_	VBD	_	_	0	ROOT	_	_
4	``	_	``	_	_	7	P	_	_
5	substantial	_	JJ	_	_	7	NMOD	_	_
6	sales	_	NNS	_	_	7	NMOD	_	_
7	growth	_	NN	_	_	3	OBJ	_	_
8	''	_	''	_	_	7	P	_	_
9	for	_	IN	_	_	7	NMOD	_	_
10	the	_	DT	_	_	16	NMOD	_	_
11	recently	_	RB	_	_	12	AMOD	_	_
12	introduced	_	VBN	_	_	16	NMOD	_	_
13	Acuvue	_	NNP	_	_	16	NMOD	_	_
14	disposable	_	JJ	_	_	16	NMOD	_	_
15	contact	_	NN	_	_	16	NMOD	_	_
16	lens	_	NN	_	_	9	PMOD	_	_
17	and	_	CC	_	_	16	COORD	_	_
18	Hismanal	_	NNP	_	_	17	CONJ	_	_
19	,	_	,	_	_	18	P	_	_
20	a	_	DT	_	_	22	NMOD	_	_
21	once-a-day	_	JJ	_	_	22	NMOD	_	_
22	antihistamine	_	NN	_	_	18	APPO	_	_
23	.	_	.	_	_	3	P	_	_

1	Eprex	_	NNP	_	_	18	SBJ	_	_
2	,	_	,	_	_	1	P	_	_
3	used	_	VBN	_	_	1	APPO	_	_
4	by	_	IN	_	_	3	LGS	_	_
5	dialysis	_	NN	_	_	6	NMOD	_	_
6	patients	_	NNS	_	_	4	PMOD	_	_
7	who	_	WP	_	_	8	SBJ	_	_
8	are	_	VBP	_	_	6	NMOD	_	_
9	anemic	_	JJ	_	_	8	PRD	_	_
10	,	_	,	_	_	1	P	_	_
11	and	_	CC	_	_	1	COORD	_	_
12	Prepulsid	_	NN	_	_	11	CONJ	_	_
13	,	_	,	_	_	12	P	_	_
14	a	_	DT	_	_	16	NMOD	_	_
15	gastro-intestinal	_	JJ	_	_	16	NMOD	_	_
16	drug	_	NN	_	_	12	APPO	_	_
17	,	_	,	_	_	1	P	_	_
18	did	_	VBD	_	_	23	OBJ	_	_
19	well	_	RB	_	_	18	MNR	_	_
20	overseas	_	RB	_	_	18	LOC	_	_
21	,	_	,	_	_	23	P	_	_
22	he	_	PRP	_	_	23	SBJ	_	_
23	said	_	VBD	_	_	0	ROOT	_	_
24	.	_	.	_	_	23	P	_	_

1	Despite	_	IN	_	_	27	ADV	_	_
2	health-care	_	NN	_	_	4	NMOD	_	_
3	cost	_	NN	_	_	4	NMOD	_	_
4	controls	_	NNS	_	_	1	PMOD	_	_
5	and	_	CC	_	_	4	COORD	_	_
6	programs	_	NNS	_	_	5	CONJ	_	_
7	to	_	TO	_	_	6	NMOD	_	_
8	hold	_	VB	_	_	7	IM	_	_
9	down	_	RP	_	_	8	PRT	_	_
10	inventory	_	NN	_	_	8	OBJ	_	_
11	,	_	,	_	_	27	P	_	_
12	the	_	DT	_	_	14	NMOD	_	_
13	professional	_	JJ	_	_	14	NMOD	_	_
14	division	_	NN	_	_	27	SBJ	_	_
15	,	_	,	_	_	14	P	_	_
16	which	_	WDT	_	_	17	SBJ	_	_
17	makes	_	VBZ	_	_	14	NMOD	_	_
18	products	_	NNS	_	_	17	OBJ	_	_
19	including	_	VBG	_	_	18	NMOD	_	_
20	sutures	_	NNS	_	_	19	PMOD	_	_
21	and	_	CC	_	_	20	COORD	_	_
22	surgical	_	JJ	_	_	24	NMOD	_	_
23	stapling	_	NN	_	_	24	NMOD	_	_
24	equipment	_	NN	_	_	21	CONJ	_	_
25	,	_	,	_	_	14	P	_	_
26	``	_	``	_	_	27	P	_	_
27	achieved	_	VBD	_	_	35	OBJ	_	_
28	solid	_	JJ	_	_	29	NMOD	_	_
29	growth	_	NN	_	_	27	OBJ	_	_
30	,	_	,	_	_	35	P	_	_
31	''	_	''	_	_	35	P	_	_
32	Johnson	_	NNP	_	_	35	SBJ	_	_
33	&	_	CC	_	_	32	COORD	_	_
34	Johnson	_	NNP	_	_	33	CONJ	_	_
35	said	_	VBD	_	_	0	ROOT	_	_
36	.	_	.	_	_	35	P	_	_

1	But	_	CC	_	_	5	DEP	_	_
2	domestic	_	JJ	_	_	4	NMOD	_	_
3	consumer	_	NN	_	_	4	NMOD	_	_
4	sales	_	NNS	_	_	5	SBJ	_	_
5	slipped	_	VBD	_	_	0	ROOT	_	_
6	1.2	_	CD	_	_	7	NMOD	_	_
7	%	_	NN	_	_	5	EXT	_	_
8	for	_	IN	_	_	5	ADV	_	_
9	the	_	DT	_	_	10	NMOD	_	_
10	quarter	_	NN	_	_	8	PMOD	_	_
11	,	_	,	_	_	5	P	_	_
12	to	_	TO	_	_	5	DIR	_	_
13	$	_	$	_	_	12	PMOD	_	_
14	490	_	CD	_	_	13	DEP	_	_
15	million	_	CD	_	_	13	DEP	_	_
16	from	_	IN	_	_	5	DIR	_	_
17	$	_	$	_	_	16	PMOD	_	_
18	496	_	CD	_	_	17	DEP	_	_
19	million	_	CD	_	_	17	DEP	_	_
20	.	_	.	_	_	5	P	_	_

1	The	_	DT	_	_	2	NMOD	_	_
2	company	_	NN	_	_	3	SBJ	_	_
3	cited	_	VBD	_	_	0	ROOT	_	_
4	softness	_	NN	_	_	3	OBJ	_	_
5	in	_	IN	_	_	4	LOC	_	_
6	the	_	DT	_	_	8	NMOD	_	_
7	retail	_	JJ	_	_	8	NMOD	_	_
8	health	_	NN	_	_	5	PMOD	_	_
9	and	_	CC	_	_	8	COORD	_	_
10	beauty	_	NN	_	_	12	NMOD	_	_
11	aids	_	NNS	_	_	12	NMOD	_	_
12	category	_	NN	_	_	9	CONJ	_	_
13	,	_	,	_	_	4	P	_	_
14	``	_	``	_	_	4	P	_	_
15	as	_	RB	_	_	4	NMOD	_	_
16	well	_	RB	_	_	4	NMOD	_	_
17	as	_	IN	_	_	4	NMOD	_	_
18	the	_	DT	_	_	20	NMOD	_	_
19	intense	_	JJ	_	_	20	NMOD	_	_
20	competition	_	NN	_	_	4	APPO	_	_
21	in	_	IN	_	_	20	LOC	_	_
22	the	_	DT	_	_	23	NMOD	_	_
23	company	_	NN	_	_	28	NMOD	_	_
24	's	_	POS	_	_	23	SUFFIX	_	_
25	sanitary	_	JJ	_	_	28	NMOD	_	_
26	protection	_	NN	_	_	28	NMOD	_	_
27	product	_	NN	_	_	28	NMOD	_	_
28	line	_	NN	_	_	21	PMOD	_	_
29	.	_	.	_	_	3	P	_	_
30	''	_	''	_	_	3	P	_	_

1	Overseas	_	JJ	_	_	2	NMOD	_	_
2	sales	_	NNS	_	_	3	SBJ	_	_
3	were	_	VBD	_	_	25	OBJ	_	_
4	stronger	_	JJR	_	_	3	PRD	_	_
5	,	_	,	_	_	3	P	_	_
6	principally	_	RB	_	_	7	PMOD	_	_
7	because	_	IN	_	_	3	PRP	_	_
8	of	_	IN	_	_	7	DEP	_	_
9	a	_	DT	_	_	10	NMOD	_	_
10	rebound	_	NN	_	_	7	PMOD	_	_
11	in	_	IN	_	_	10	LOC	_	_
12	Brazil	_	NNP	_	_	11	PMOD	_	_
13	,	_	,	_	_	12	P	_	_
14	where	_	WRB	_	_	18	LOC	_	_
15	economic	_	JJ	_	_	16	NMOD	_	_
16	turmoil	_	NN	_	_	17	SBJ	_	_
17	had	_	VBD	_	_	12	NMOD	_	_
18	hurt	_	VBN	_	_	17	VC	_	_
19	year-earlier	_	JJ	_	_	20	NMOD	_	_
20	results	_	NNS	_	_	18	OBJ	_	_
21	,	_	,	_	_	25	P	_	_
22	Johnson	_	NNP	_	_	25	SBJ	_	_
23	&	_	CC	_	_	22	COORD	_	_
24	Johnson	_	NNP	_	_	23	CONJ	_	_
25	said	_	VBD	_	_	0	ROOT	_	_
26	.	_	.	_	_	25	P	_	_

1	Mr.	_	NNP	_	_	2	TITLE	_	_
2	Lothson	_	NNP	_	_	5	SBJ	_	_
3	of	_	IN	_	_	2	NMOD	_	_
4	PaineWebber	_	NNP	_	_	3	PMOD	_	_
5	said	_	VBD	_	_	0	ROOT	_	_
6	the	_	DT	_	_	7	NMOD	_	_
7	company	_	NN	_	_	10	NMOD	_	_
8	's	_	POS	_	_	7	SUFFIX	_	_
9	sales	_	NNS	_	_	10	NMOD	_	_
10	pace	_	NN	_	_	11	SBJ	_	_
11	has	_	VBZ	_	_	5	OBJ	_	_
12	been	_	VBN	_	_	11	VC	_	_
13	picking	_	VBG	_	_	12	VC	_	_
14	up	_	RP	_	_	13	PRT	_	_
15	largely	_	RB	_	_	16	ADV	_	_
16	because	_	IN	_	_	13	PRP	_	_
17	the	_	DT	_	_	18	NMOD	_	_
18	effect	_	NN	_	_	23	SBJ	_	_
19	of	_	IN	_	_	18	NMOD	_	_
20	unfavorable	_	JJ	_	_	22	NMOD	_	_
21	exchange	_	NN	_	_	22	NMOD	_	_
22	rates	_	NNS	_	_	19	PMOD	_	_
23	has	_	VBZ	_	_	16	SUB	_	_
24	been	_	VBN	_	_	23	VC	_	_
25	easing	_	VBG	_	_	24	VC	_	_
26	--	_	:	_	_	25	P	_	_
27	a	_	DT	_	_	28	NMOD	_	_
28	pattern	_	NN	_	_	25	ADV	_	_
29	continuing	_	VBG	_	_	28	APPO	_	_
30	this	_	DT	_	_	31	NMOD	_	_
31	quarter	_	NN	_	_	29	TMP	_	_
32	.	_	.	_	_	5	P	_	_

1	He	_	PRP	_	_	2	SBJ	_	_
2	cautioned	_	VBD	_	_	0	ROOT	_	_
3	,	_	,	_	_	2	P	_	_
4	however	_	RB	_	_	2	ADV	_	_
5	,	_	,	_	_	2	P	_	_
6	that	_	IN	_	_	2	OBJ	_	_
7	a	_	DT	_	_	11	NMOD	_	_
8	``	_	``	_	_	11	P	_	_
9	tough	_	JJ	_	_	11	NMOD	_	_
10	tax-rate	_	NN	_	_	11	NMOD	_	_
11	comparison	_	NN	_	_	13	SBJ	_	_
12	''	_	''	_	_	11	P	_	_
13	may	_	MD	_	_	6	SUB	_	_
14	slow	_	VB	_	_	13	VC	_	_
15	the	_	DT	_	_	16	NMOD	_	_
16	company	_	NN	_	_	19	NMOD	_	_
17	's	_	POS	_	_	16	SUFFIX	_	_
18	earnings	_	NNS	_	_	19	NMOD	_	_
19	growth	_	NN	_	_	14	OBJ	_	_
20	for	_	IN	_	_	19	NMOD	_	_
21	the	_	DT	_	_	23	NMOD	_	_
22	current	_	JJ	_	_	23	NMOD	_	_
23	quarter	_	NN	_	_	20	PMOD	_	_
24	.	_	.	_	_	2	P	_	_

1	For	_	IN	_	_	13	ADV	_	_
2	last	_	JJ	_	_	3	NMOD	_	_
3	year	_	NN	_	_	6	NMOD	_	_
4	's	_	POS	_	_	3	SUFFIX	_	_
5	fourth	_	JJ	_	_	6	NMOD	_	_
6	quarter	_	NN	_	_	1	PMOD	_	_
7	,	_	,	_	_	13	P	_	_
8	the	_	DT	_	_	9	NMOD	_	_
9	company	_	NN	_	_	12	NMOD	_	_
10	's	_	POS	_	_	9	SUFFIX	_	_
11	tax	_	NN	_	_	12	NMOD	_	_
12	rate	_	NN	_	_	13	SBJ	_	_
13	was	_	VBD	_	_	20	OBJ	_	_
14	less	_	JJR	_	_	16	DEP	_	_
15	than	_	IN	_	_	16	DEP	_	_
16	20	_	CD	_	_	17	NMOD	_	_
17	%	_	NN	_	_	13	PRD	_	_
18	,	_	,	_	_	20	P	_	_
19	he	_	PRP	_	_	20	SBJ	_	_
20	said	_	VBD	_	_	0	ROOT	_	_
21	.	_	.	_	_	20	P	_	_

1	While	_	IN	_	_	16	ADV	_	_
2	the	_	DT	_	_	4	NMOD	_	_
3	third	_	JJ	_	_	4	NMOD	_	_
4	period	_	NN	_	_	5	SBJ	_	_
5	contained	_	VBD	_	_	1	SUB	_	_
6	no	_	DT	_	_	8	NMOD	_	_
7	major	_	JJ	_	_	8	NMOD	_	_
8	surprises	_	NNS	_	_	5	OBJ	_	_
9	,	_	,	_	_	12	P	_	_
10	Mr.	_	NNP	_	_	11	TITLE	_	_
11	Lothson	_	NNP	_	_	12	SBJ	_	_
12	said	_	VBD	_	_	0	ROOT	_	_
13	,	_	,	_	_	12	P	_	_
14	the	_	DT	_	_	15	NMOD	_	_
15	results	_	NNS	_	_	16	SBJ	_	_
16	show	_	VBP	_	_	12	OBJ	_	_
17	how	_	WRB	_	_	22	PRD	_	_
18	sensitive	_	JJ	_	_	17	AMOD	_	_
19	the	_	DT	_	_	20	NMOD	_	_
20	multinationals	_	NNS	_	_	21	SBJ	_	_
21	can	_	MD	_	_	16	OBJ	_	_
22	be	_	VB	_	_	21	VC	_	_
23	to	_	TO	_	_	22	ADV	_	_
24	developments	_	NNS	_	_	23	PMOD	_	_
25	in	_	IN	_	_	24	LOC	_	_
26	a	_	DT	_	_	28	NMOD	_	_
27	single	_	JJ	_	_	28	NMOD	_	_
28	country	_	NN	_	_	25	PMOD	_	_
29	such	_	JJ	_	_	28	NMOD	_	_
30	as	_	IN	_	_	28	NMOD	_	_
31	Brazil	_	NNP	_	_	28	APPO	_	_
32	.	_	.	_	_	16	P	_	_

1	He	_	PRP	_	_	3	SBJ	_	_
2	also	_	RB	_	_	3	ADV	_	_
3	questioned	_	VBD	_	_	0	ROOT	_	_
4	whether	_	IN	_	_	3	OBJ	_	_
5	recent	_	JJ	_	_	6	NMOD	_	_
6	gains	_	NNS	_	_	10	SBJ	_	_
7	in	_	IN	_	_	6	LOC	_	_
8	that	_	DT	_	_	9	NMOD	_	_
9	country	_	NN	_	_	7	PMOD	_	_
10	can	_	MD	_	_	4	SUB	_	_
11	be	_	VB	_	_	10	VC	_	_
12	sustained	_	VBN	_	_	11	VC	_	_
13	.	_	.	_	_	3	P	_	_

1	The	_	DT	_	_	3	NMOD	_	_
2	following	_	JJ	_	_	3	NMOD	_	_
3	issues	_	NNS	_	_	4	SBJ	_	_
4	were	_	VBD	_	_	0	ROOT	_	_
5	recently	_	RB	_	_	4	TMP	_	_
6	filed	_	VBN	_	_	4	VC	_	_
7	with	_	IN	_	_	6	ADV	_	_
8	the	_	DT	_	_	9	NMOD	_	_
9	Securities	_	NNP	_	_	7	PMOD	_	_
10	and	_	CC	_	_	9	COORD	_	_
11	Exchange	_	NNP	_	_	12	NAME	_	_
12	Commission	_	NNP	_	_	10	CONJ	_	_
13	:	_	:	_	_	4	P	_	_

1	Bergen	_	NNP	_	_	2	NAME	_	_
2	Brunswig	_	NNP	_	_	0	ROOT	_	_
3	Corp.	_	NNP	_	_	2	POSTHON	_	_
4	,	_	,	_	_	2	P	_	_
5	proposed	_	JJ	_	_	6	NMOD	_	_
6	offering	_	NN	_	_	2	APPO	_	_
7	of	_	IN	_	_	6	NMOD	_	_
8	liquid	_	JJ	_	_	11	NMOD	_	_
9	yield	_	NN	_	_	11	NMOD	_	_
10	option	_	NN	_	_	11	NMOD	_	_
11	notes	_	NNS	_	_	7	PMOD	_	_
12	,	_	,	_	_	2	P	_	_
13	via	_	IN	_	_	2	NMOD	_	_
14	Merrill	_	NNP	_	_	17	NAME	_	_
15	Lynch	_	NNP	_	_	17	NAME	_	_
16	Capital	_	NNP	_	_	17	NAME	_	_
17	Markets	_	NNP	_	_	13	PMOD	_	_
18	.	_	.	_	_	2	P	_	_

1	Columbia	_	NNP	_	_	3	NAME	_	_
2	Gas	_	NNP	_	_	3	NAME	_	_
3	System	_	NNP	_	_	0	ROOT	_	_
4	Inc.	_	NNP	_	_	3	POSTHON	_	_
5	,	_	,	_	_	3	P	_	_
6	shelf	_	NN	_	_	7	NMOD	_	_
7	offering	_	NN	_	_	3	APPO	_	_
8	of	_	IN	_	_	7	NMOD	_	_
9	up	_	IN	_	_	11	DEP	_	_
10	to	_	TO	_	_	11	DEP	_	_
11	$	_	$	_	_	8	PMOD	_	_
12	200	_	CD	_	_	11	DEP	_	_
13	million	_	CD	_	_	11	DEP	_	_
14	of	_	IN	_	_	11	NMOD	_	_
15	debentures	_	NNS	_	_	14	PMOD	_	_
16	.	_	.	_	_	3	P	_	_

1	Laserscope	_	NNP	_	_	0	ROOT	_	_
2	,	_	,	_	_	1	P	_	_
3	initial	_	JJ	_	_	4	NMOD	_	_
4	offering	_	NN	_	_	1	APPO	_	_
5	of	_	IN	_	_	4	NMOD	_	_
6	1,656,870	_	CD	_	_	8	NMOD	_	_
7	common	_	JJ	_	_	8	NMOD	_	_
8	shares	_	NNS	_	_	5	PMOD	_	_
9	,	_	,	_	_	8	P	_	_
10	of	_	IN	_	_	13	NMOD	_	_
11	which	_	WDT	_	_	10	PMOD	_	_
12	1,455,000	_	CD	_	_	13	NMOD	_	_
13	shares	_	NNS	_	_	14	SBJ	_	_
14	are	_	VBP	_	_	8	NMOD	_	_
15	to	_	TO	_	_	14	VC	_	_
16	be	_	VB	_	_	15	IM	_	_
17	sold	_	VBN	_	_	16	VC	_	_
18	by	_	IN	_	_	17	LGS	_	_
19	the	_	DT	_	_	20	NMOD	_	_
20	company	_	NN	_	_	18	PMOD	_	_
21	and	_	CC	_	_	14	COORD	_	_
22	201,870	_	CD	_	_	21	GAP-SBJ	_	_
23	by	_	IN	_	_	21	GAP-LGS	_	_
24	holders	_	NNS	_	_	23	PMOD	_	_
25	,	_	,	_	_	4	P	_	_
26	via	_	IN	_	_	4	NMOD	_	_
27	Alex	_	NNP	_	_	29	NMOD	_	_
28	.	_	.	_	_	29	P	_	_
29	Brown	_	NNP	_	_	26	PMOD	_	_
30	&	_	CC	_	_	29	COORD	_	_
31	Sons	_	NNP	_	_	30	CONJ	_	_
32	Inc.	_	NNP	_	_	31	POSTHON	_	_
33	and	_	CC	_	_	31	COORD	_	_
34	Volpe	_	NNP	_	_	33	CONJ	_	_
35	,	_	,	_	_	34	P	_	_
36	Covington	_	NNP	_	_	34	COORD	_	_
37	&	_	CC	_	_	36	COORD	_	_
38	Welty	_	NNP	_	_	37	CONJ	_	_
39	.	_	.	_	_	1	P	_	_

1	TeleVideo	_	NNP	_	_	2	NAME	_	_
2	Systems	_	NNP	_	_	0	ROOT	_	_
3	Inc.	_	NNP	_	_	2	POSTHON	_	_
4	,	_	,	_	_	2	P	_	_
5	proposed	_	JJ	_	_	6	NMOD	_	_
6	offering	_	NN	_	_	2	APPO	_	_
7	of	_	IN	_	_	6	NMOD	_	_
8	1,853,735	_	CD	_	_	10	NMOD	_	_
9	common	_	JJ	_	_	10	NMOD	_	_
10	shares	_	NNS	_	_	7	PMOD	_	_
11	,	_	,	_	_	10	P	_	_
12	to	_	TO	_	_	10	NMOD	_	_
13	be	_	VB	_	_	12	IM	_	_
14	sold	_	VBN	_	_	13	VC	_	_
15	by	_	IN	_	_	14	LGS	_	_
16	holders	_	NNS	_	_	15	PMOD	_	_
17	.	_	.	_	_	2	P	_	_

1	Western	_	NNP	_	_	3	NAME	_	_
2	Gas	_	NNP	_	_	3	NAME	_	_
3	System	_	NNP	_	_	0	ROOT	_	_
4	Inc.	_	NNP	_	_	3	POSTHON	_	_
5	,	_	,	_	_	3	P	_	_
6	initial	_	JJ	_	_	7	NMOD	_	_
7	offering	_	NN	_	_	3	APPO	_	_
8	of	_	IN	_	_	7	NMOD	_	_
9	3,250,000	_	CD	_	_	11	NMOD	_	_
10	common	_	JJ	_	_	11	NMOD	_	_
11	shares	_	NNS	_	_	8	PMOD	_	_
12	,	_	,	_	_	11	P	_	_
13	of	_	IN	_	_	16	NMOD	_	_
14	which	_	WDT	_	_	13	PMOD	_	_
15	3,040,000	_	CD	_	_	16	NMOD	_	_
16	shares	_	NNS	_	_	17	SBJ	_	_
17	will	_	MD	_	_	11	NMOD	_	_
18	be	_	VB	_	_	17	VC	_	_
19	sold	_	VBN	_	_	18	VC	_	_
20	by	_	IN	_	_	19	LGS	_	_
21	the	_	DT	_	_	22	NMOD	_	_
22	company	_	NN	_	_	20	PMOD	_	_
23	and	_	CC	_	_	17	COORD	_	_
24	210,000	_	CD	_	_	23	GAP-SBJ	_	_
25	by	_	IN	_	_	23	GAP-LGS	_	_
26	a	_	DT	_	_	27	NMOD	_	_
27	holder	_	NN	_	_	25	PMOD	_	_
28	,	_	,	_	_	7	P	_	_
29	via	_	IN	_	_	7	NMOD	_	_
30	Prudential-Bache	_	NNP	_	_	32	NAME	_	_
31	Capital	_	NNP	_	_	32	NAME	_	_
32	Funding	_	NNP	_	_	29	PMOD	_	_
33	,	_	,	_	_	32	P	_	_
34	Smith	_	NNP	_	_	35	NAME	_	_
35	Barney	_	NNP	_	_	32	COORD	_	_
36	,	_	,	_	_	35	P	_	_
37	Harris	_	NNP	_	_	38	NAME	_	_
38	Upham	_	NNP	_	_	35	COORD	_	_
39	&	_	CC	_	_	38	COORD	_	_
40	Co.	_	NNP	_	_	41	COORD	_	_
41	and	_	CC	_	_	39	CONJ	_	_
42	Hanifen	_	NNP	_	_	44	NAME	_	_
43	,	_	,	_	_	44	P	_	_
44	Imhoff	_	NNP	_	_	41	CONJ	_	_
45	Inc	_	NNP	_	_	44	POSTHON	_	_
46	.	_	.	_	_	3	P	_	_

